Resultados de procura - Kristin Bergethon
- Mostrando 1 - 8 Resultados de 8
-
1
-
2
Histologic and cytomorphologic features of ALK-rearranged lung adenocarcinomas por Michiya Nishino, Veronica Klepeis, Beow Y. Yeap, Kristin Bergethon, Vicente Morales‐Oyarvide, Dora Dias‐Santagata, Yukako Yagi, Eugene J. Mark, A. John Iafrate, Mari Mino‐Kenudson
Publicado 2012Artigo -
3
Trends in 30-Day Readmission Rates for Patients Hospitalized With Heart Failure por Kristin Bergethon, Christine Ju, Adam D. DeVore, N. Chantelle Hardy, Gregg C. Fonarow, Clyde W. Yancy, Paul A. Heidenreich, Deepak L. Bhatt, Eric D. Peterson, Adrian F. Hernandez
Publicado 2016Artigo -
4
<i>MET</i> Amplification Identifies a Small and Aggressive Subgroup of Esophagogastric Adenocarcinoma With Evidence of Responsiveness to Crizotinib por Jochen K. Lennerz, Eunice L. Kwak, A. B. Ackerman, Michael Michael, Stephen B. Fox, Kristin Bergethon, Gregory Y. Lauwers, James G. Christensen, Keith D. Wilner, Daniel A. Haber, Ravi Salgia, Yung‐Jue Bang, Jeffrey W. Clark, Benjamin Solomon, A. John Iafrate
Publicado 2011Artigo -
5
Activity of Crizotinib (PF02341066), a Dual Mesenchymal-Epithelial Transition (MET) and Anaplastic Lymphoma Kinase (ALK) Inhibitor, in a Non-small Cell Lung Cancer Patient with De... por Sai‐Hong Ignatius Ou, Eunice L. Kwak, Christina T. Siwak-Tapp, Joni Dy, Kristin Bergethon, Jeffrey W. Clark, D. Ross Camidge, Benjamin Solomon, Robert G. Maki, Yung‐Jue Bang, Dong‐Wan Kim, James G. Christensen, Weiwei Tan, Keith D. Wilner, Ravi Salgia, A. John Iafrate
Publicado 2011Artigo -
6
Activation of PI3K Signaling in Merkel Cell Carcinoma por Valentina Nardi, Youngchul Song, Juan A. Santamaria‐Barria, Arjola K. Cosper, Quynh Lam, Anthony C. Faber, Genevieve M. Boland, Beow Y. Yeap, Kristin Bergethon, Vanessa Scialabba, Hensin Tsao, Jeffrey Settleman, David P. Ryan, Darrell R. Borger, Atul K. Bhan, Mai P. Hoang, A. John Iafrate, James C. Cusack, Jeffrey A. Engelman, Dora Dias‐Santagata
Publicado 2012Artigo -
7
Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors por Lecia V. Sequist, Belinda A. Waltman, Dora Dias‐Santagata, Subba R. Digumarthy, Alexa B. Turke, Panos Fidias, Kristin Bergethon, Alice T. Shaw, Scott Gettinger, Arjola K. Cosper, Sara Akhavanfard, Rebecca S. Heist, Jennifer S. Temel, James G. Christensen, John C. Wain, Thomas J. Lynch, Kathy Vernovsky, Eugene J. Mark, Michael Lanuti, A. John Iafrate, Mari Mino‐Kenudson, Jeffrey A. Engelman
Publicado 2011Artigo -
8
<i>ROS1</i> Rearrangements Define a Unique Molecular Class of Lung Cancers por Kristin Bergethon, Alice T. Shaw, Sai‐Hong Ignatius Ou, Ryohei Katayama, Christine M. Lovly, Nerina T. McDonald, Pierre P. Massion, Christina T. Siwak-Tapp, Adriana González, Rong Fang, Eugene J. Mark, Julie M. Batten, Haiquan Chen, Keith D. Wilner, Eunice L. Kwak, Jeffrey W. Clark, David P. Carbone, Hongbin Ji, Jeffrey A. Engelman, Mari Mino‐Kenudson, William Pao, A. John Iafrate
Publicado 2012Artigo
Ferramentas de procura:
Materias Relacionadas
Biology
Medicine
Gene
Cancer
Cancer research
Internal medicine
Lung cancer
Crizotinib
Genetics
Malignant pleural effusion
Pathology
Adenocarcinoma
Anaplastic lymphoma kinase
Chromosome
Fluorescence in situ hybridization
Gene rearrangement
Oncology
Biochemistry
Carcinoma
Lung
Mutation
Receptor
Tyrosine kinase
ALK inhibitor
Biopsy
Cell biology
Cohort
Colorectal cancer
Confidence interval
Cytology